Characterising the prognostic potential of HLA-DR during colorectal cancer development
2020 · Cancer Immunology Immunotherapy · 35 citations
https://doi.org/10.1007/s00262-020-02571-2
D
D. Fennelly
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
149
Papers
3.4K
Citations
29
h-index
55
i10-index
D. Fennelly is an academic researcher from St. Vincent's University Hospital. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Colorectal Cancer Treatments and Studies & Breast Cancer Treatment Studies. The author has an h-index of 29, co-authored 127 publications.
Papers by this author
worksTumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
2014 · British Journal of Cancer · 34 citations
https://doi.org/10.1038/bjc.2014.367
Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
2014 · BMC Cancer · 33 citations
https://doi.org/10.1186/1471-2407-14-887
Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project
2018 · British Journal of Cancer · 17 citations
https://doi.org/10.1038/s41416-018-0114-x
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer
2018 · BJS Open · 13 citations
https://doi.org/10.1002/bjs5.91
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat